The pharmaceutical industry in the United States is experiencing a rapid surge in need for Tirzepatide APIs. This powerful medication, used to treat type 2 diabetes, has gained extensive attention from both patients and doctors. As a result, numerous manufacturers have emerged as makers of Tirzepati